Article
Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics.
BMC medical imaging - 23 Dec 2024
Li Zhina, Wang Cheng, Li Jianbo, Wang Xingxing, Li Xiang, Yu Tianzhu, Zhou Jianjun, Wang Xiaolin, Zeng Mengsu, Sun Haitao
Abstract excerpt
AIM: To assess the value of preoperatively contrast-enhanced MRI and clinical characteristics for identification of SMAD4-mutated pancreatic ductal adenocarcinoma (PDAC) patients. MATERIALS AND METHODS: This retrospective study included patients with surgically confirmed PDAC from January 2016 to December 2022. Based on immunostaining results indicating the mutation of SMAD4, the enrolled participants were...
Topics
Join the communities discussing this publication.
